Results 251 to 260 of about 1,635,060 (314)

Upfront triple combination therapy with selexipag: insights from a real world cohort in Chinese patients with pulmonary arterial hypertension. [PDF]

Front Cardiovasc Med
Cui X, Hu X, Qin X, Li H, Xu X, Liu H, Ji Q.   +6 more
europepmc   +1 more source

Deciphering the pharmacological paradox: mechanism mismatch and stratification inadequacies in herbal-NSAID combination therapy. [PDF]

Int J Surg
Huang J, Wang B, Zhan Q.
europepmc   +1 more source

Nanoparticle-Based Combination Therapy for Ovarian Cancer

International Journal of Nanomedicine, 2023
Yingli Wu,1– 3,* Yu Yang,1– 3,* Xiaolin Lv,1– 3 Menghan Gao,1 Xujin Gong,1– 3 Qingqiang Yao,1– 4 Yanna Liu1– 3 1School of Pharmacy and Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of ...
Yingli Wu, Yu Yang, Xiaolin Lv
exaly   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Combination Therapy

Neurological Sciences, 2006
So far, off-label recommendation of a combination therapy is mainly based on phase II study evidence and on largely accepted expert opinions. Combination therapy represents a new, more global strategy, to increase the possible benefits with the combined use of already available disease-modifying therapies or with other new agents, having an acceptable ...
openaire   +3 more sources